High-intensity focused ultrasound (HIFU) may have the potential to replace drug therapy for cancer patients when combined with surgery, radiation therapy or chemotherapy, according to new research published online in the March-April 2018 issue of Radiographics.

A group of international researchers has developed a point-of-care device that may produce a consistent and cost-effective screening method for thyroid nodules.

The new technology promises to eliminate the human subjectivity and variability in grading cancer tumors, according to research published in Convergent Science Physical Oncology.

T2 weighted-based radiomics proved superior in classification performance than qualitative assessment and diffusion-weighted (DW) imaging for diagnosing pathologic complete response (pCR) in patients with rectal cancer who received therapy prior to their main treatment, according to a study in Radiology.

One-time prostate-specific antigen (PSA) cancer screenings in men does not improve mortality rates for the disease, according to a study published online March 6 in JAMA.

Zika virus has had a significant impact in North and South America, most notably by causing microcephaly in babies born to infected mothers. But Brazilian researchers have found the deadly virus may be an effective treatment for glioblastoma—the most common and aggressive form of malignant brain tumor in adults.

In patients with early-stage breast cancer, neoadjuvant chemotherapy (NAC) is a common treatment to reduce tumor size before surgery. A team has found dynamic diffuse optical tomography (DDOT) can detect if a tumor has responded to chemotherapy within two weeks of initial treatment—potentially life-saving information for patients. ​​​​​​​

Pairing ultrasound with a blood test to detect high alpha fetoprotein (AFP) levels demonstrated up to a 40 percent improvement in detecting early-stage liver cancer, according to new research published in the journal Gastroenterology.